Post job

Acariahealth, Inc. main competitors are DURECT, Provell Pharmaceuticals, and Affinity Health.

Competitor Summary. See how Acariahealth, Inc. compares to its main competitors:

  • CCS Medical has the most employees (3,000).
  • Employees at DURECT earn more than most of the competitors, with an average yearly salary of $76,438.
Work at Acariahealth, Inc.?
Share your experience

Acariahealth, Inc. vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
-
3.6
Orlando, FL1$5.4M3,000
1998
4.1
Cupertino, CA3$2.0M88
Provell Pharmaceuticals
2005
3.9
Honey Brook, PA1$10.0M5
2006
4.1
San Diego, CA1$12.0M175
1996
4.6
Somers Point, NJ1$50.0M500
Affinity Health
-
4.7
Appleton, WI1$4.0M15
Biomed Specialty Pharmacy
-
4.1
Southfield, MI1$1.3M15
2001
4.1
Andover, MA1$70.6M202
1987
4.4
Elk Grove Village, IL1$405.0M750
1994
4.2
Lake Mary, FL1$18.0M378
2005
4.3
Coppell, TX1$34.9M291
1998
4.0
Omaha, NE1$15.4M35
1998
4.4
San Diego, CA2$48.9M143
1994
4.3
Farmers Branch, TX12$280.0M3,000

Rate Acariahealth, Inc.'s competitiveness in the market.

Zippia waving zebra

Acariahealth, Inc. salaries vs competitors

Among Acariahealth, Inc. competitors, employees at DURECT earn the most with an average yearly salary of $76,438.

Compare Acariahealth, Inc. salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Acariahealth, Inc.
$54,732$26.31-
DURECT
$76,438$36.75-
Provell Pharmaceuticals
$65,016$31.26-
Nabriva Therapeutics
$50,192$24.13-
Home Infusion Solutions
$45,809$22.02-
Affinity Health
$64,947$31.22-

Compare Acariahealth, Inc. job title salaries vs competitors

CompanyHighest salaryHourly salary
Acariahealth, Inc.
$71,409$34.33
DURECT
$87,612$42.12
Nabriva Therapeutics
$74,477$35.81
Injured Workers Pharmacy
$70,946$34.11
Affinity Health
$70,886$34.08
CuraScript SD
$70,691$33.99
CCS Medical
$70,535$33.91
Provell Pharmaceuticals
$70,484$33.89
Orsini Specialty Pharmacy
$70,145$33.72
Davita Rx
$70,052$33.68
Amber Pharmacy
$69,975$33.64
Home Infusion Solutions
$69,690$33.50
Imprimis Pharmaceuticals
$68,541$32.95
Biomed Specialty Pharmacy
$68,310$32.84

Do you work at Acariahealth, Inc.?

Is Acariahealth, Inc. able to compete effectively with similar companies?

Acariahealth, Inc. jobs

Acariahealth, Inc. demographics vs competitors

Compare gender at Acariahealth, Inc. vs competitors

Job titleMaleFemale
Amber Pharmacy26%74%
CCS Medical31%69%
Davita Rx34%66%
Orsini Specialty Pharmacy41%59%
DURECT50%50%
Acariahealth, Inc.--

Compare race at Acariahealth, Inc. vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
37%19%7%28%9%
8.5
60%16%15%6%3%
8.8
69%16%6%6%3%
7.4
58%18%11%7%6%
9.1
50%26%13%9%2%
8.7

Acariahealth, Inc. and similar companies CEOs

CEOBio
James Brown D.v.m
DURECT

James E. Brown, D.V.M. co-founded DURECT in February 1998 and has served as President, Chief Executive Officer and a Director since June 1998. He previously worked at ALZA Corporation as Vice President of Biopharmaceutical and Implant Research and Development from June 1995 to June 1998. Prior to that, Dr. Brown held various positions at Syntex Corporation, a pharmaceutical company, including Director of Business Development from May 1994 to May 1995, Director of Joint Ventures for Discovery Research from April 1992 to May 1995, and held a number of positions including Program Director for Syntex Research and Development from October 1985 to March 1992. Dr. Brown holds a B.A. from San Jose State University and a D.V.M. (Doctor of Veterinary Medicine) from the University of California, Davis where he also conducted post-graduate work in pharmacology and toxicology.

Mark L. Baum is the founder and CEO of Imprimis Pharmaceuticals whose mission is to provide patients and physicians with innovative and affordable ophthalmic drugs in the ocular surgery, glaucoma, and dry eye disease markets. He is also a founder and board member of Eton Pharmaceuticals and Surface Pharmaceuticals, as well as a board member and chairman of the audit committee of Ideal Power. He was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Prior to Imprimis, as the founder of TBLF, LLC, a private investment fund, He made more than 200 investments into more than 40 private and public companies. In 1999, He founded YesRx, an HIV-focused pharmacy business. He's advocacy for drug pricing and accessibility issues has been reflected as an Op-Ed contributor for the Wall Street Journal and through appearances on CBS, CNN, MSNBC, Fox Business, Bloomberg and Al Jazeera. He is a 1995 cum laude graduate of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.

William Korslin
CCS Medical

William Korslin is a Chief Executive Officer at CCS Medical and is based in Harvard, Illinois. He works or has worked as CEO at Centrad Healthcare LLC.

Mr. Luis E. Dini
Home Infusion Solutions

Mr. Luis E. Dini is a Chairman - Chief Executive Officer at Home Solutions and is based in United States.

Jim Small
Provell Pharmaceuticals

Jim Small co-founded Provell Pharmaceuticals and currently serves as Chief Executive Officer. He brings over 30 years of Pharmaceutical Sales, Marketing, and Drug Development experience having worked with several large pharmaceutical companies.

Michael Gavin is a President/CEO at IWP (Injured Workers Pharmacy) and is based in Atlanta, Georgia. He has worked as Senior Manager at Kurt Salmon, VP of Operations at SPH Analytics, and Consultant at Monitor Group. Michael works or has worked as VP:Operations at MDdatacor and President at PRIUM. He studied at Emory University between 2006 and 2007, Emory University - Goizueta Business School between 2006 and 2007, and Georgetown McDonough School of Business between 1997 and 2000.

Michael Fieri joined Orsini Healthcare as Founder and Chief Executive Officer at Michael attended Quinlan School of Business, Loyola University Chicago.

Andrew R. Jassy
Davita Rx

Theodore R. Schroeder
Nabriva Therapeutics

Acariahealth, Inc. competitors FAQs

Search for jobs